CI Global Health Sciences Corporate Class

Series A CAD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Fund details

description of elementelement value
Inception date July 1996
CAD Total net assets ($CAD)
As at 2024-08-30
$170.2 million
NAVPS
As at 2024-09-17
$57.8866
MER (%)
As at 2024-03-31
2.33
Management fee (%) 1.90
Asset class Sector Equity
Currency CAD
Minimum investment $500 initial/$25 additional
Distribution frequency Quarterly
Last distribution $0.9027

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

A ISC 201
DSC SO* 701
LL SO 1701
E 16005
EF 15005
F 224
I 886
O 18005
P 90024
*No new purchases directly into switch only funds.

Performance2 As at 2024-08-31

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
16.33% 2.77% 7.11% 7.52% 16.40% 3.28% 9.18% 4.42% 8.08%
*Since inception date

Distribution history3

Payable date Total
2022-03-25 0.9027
2021-03-26 0.3135
2020-12-18 0.5081
2020-09-25 0.5058
2020-06-26 0.3780
Payable date Total
2020-03-20 0.9301
2019-12-13 0.5339
2019-09-27 0.5996
2019-06-21 0.5646
2019-03-22 0.9043

CI PREFERRED PRICING4

Investment amount Combined fee reduction
$100,000 - $500,000 0.03%
$500,000 - $1,000,000 0.06%
$1,000,000 - $2,500,000 0.12%
$2,500,000 - $5,000,000 0.20%
$5,000,000 and above 0.32%

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Peter Hofstra

CI Global Health Sciences Corporate Class

Series A CAD
 
Portfolio allocations5 As at 2024-08-31
Asset allocation (%)
  • US Equity 77.05
  • International Equity 22.13
  • Cash and Equivalents 0.84
  • Other -0.02
Sector allocation (%)
  • Healthcare 95.55
  • Exchange Traded Fund 2.69
  • Consumer Services 0.94
  • Cash and Cash Equivalent 0.84
  • Other -0.02
Geographic allocation(%)
  • United States 77.76
  • Denmark 8.39
  • United Kingdom 6.65
  • Switzerland 4.28
  • Germany 2.86
  • Canada 0.08
  • Other -0.02
Top holdings
Sector (%)
1. Eli Lilly and Co Drugs 11.46%
2. UnitedHealth Group Inc Healthcare Services 10.42%
3. Novo Nordisk A/S Cl B Drugs 7.39%
4. AstraZeneca PLC Drugs 6.63%
5. Humana Inc Healthcare Services 4.63%
6. Merck & Co Inc Drugs 4.45%
7. Zoetis Inc Cl A Drugs 4.43%
8. AbbVie Inc Drugs 3.88%
9. Thermo Fisher Scientific Inc Healthcare Equipment 3.80%
10. Cigna Corp Healthcare Services 3.26%
11. Boston Scientific Corp Healthcare Equipment 3.21%
12. Intuitive Surgical Inc Healthcare Equipment 2.97%
13. Elevance Health Inc Diversified Healthcare 2.95%
14. Siemens Healthineers AG Healthcare Equipment 2.86%
15. Roche Holding AG - Partcptn Drugs 2.74%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.